BALA CYNWYD, PA / ACCESSWIRE / December 18, 2019 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590. There is no cost or financial obligation to you.

ARQULE, INC. (NASDAQGS:ARQL)

Under the terms of the agreement, ArQule shareholders will receive only $20.00 for each share of ArQule common stock owned. The investigation concerns whether the ArQule Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Merck is underpaying for the Company. For example, ArQule's lead new drug candidate under development, called ARQ 531, is a potential treatment of B-cell malignancies including relapsed or refractory chronic lymphocytic leukemia. Merck's President commented, "ArQule's focus on precision medicine has yielded multiple clinical-stage oral kinase inhibitors that have novel and important properties, …. This acquisition strengthens Merck's pipeline with the addition of these strategic assets."

Additional information can be found at http://www.brodskysmith.com/cases/arqule-inc-nasdaqgs-arql/, or call 877-534-2590. No cost or obligation to you.

AUDENTES THERAPEUTICS, INC. (NASDAQGS:BOLD)

Under the terms of the agreement, Audentes shareholders will receive only $60.00 for each share of Audentes common stock owned. The investigation concerns whether the Audentes Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Astellas Pharma, Inc.is underpaying for the Company. The transaction may undervalue the Company. For example, the merger will provide Astellas with Audentes robust pipeline, including its lead program AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM).

Additional information can be found at http://www.brodskysmith.com/cases/audentes-therapeutics-inc-nasdaqgs-bold/, or call 877-534-2590. No cost or obligation to you.

SYNTHORX, INC. (NASDAQGS:THOR)

Under the terms of the agreement, Synthorx shareholders will receive only $68.00 for each share of Synthorx common stock owned. The investigation concerns whether the Synthorx Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Sanofi is underpaying for the Company. For example, the drug at the center of the deal is Synthorx's investigational medicine code-named THOR-707. Meant to treat solid tumors, the drug is designed to boost the number of cancer-fighting cells in the body, potentially overwhelming the disease with effector T-cells and natural killer cells.

Additional information can be found at http://www.brodskysmith.com/cases/synthorx-inc-nasdaqgs-thor/, or call 877-534-2590. No cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 570671

NEW YORK, NY / ACCESSWIRE / December 18, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action filed on behalf of investors that purchased or acquired the securities of Adamas Pharmaceuticals, Inc. ("Adamas" or the "Company") (NASDAQ:ADMS) between August 8, 2017, and September 30, 2019, inclusive (the "Class Period"). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased Adamas securities, and/or would like to discuss your legal rights and options please visit Adamas Shareholder Class Action or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements, and failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, it is alleged that Defendants made materially false and misleading statements about: (1) managed care's acceptance of GOCOVRI; (2) the breadth of insurer coverage for GOCOVRI prescriptions; and (3) the impact of the Company's commercialization efforts. In addition, it is alleged that Defendants failed to disclose: (1) that health insurers were excluding GOCOVRI from their prescription formularies or requiring patients to use "step therapy" – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) that the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) that, as a result of the foregoing, the Company's financial statements and Defendants' statements about Adamas's business, operations, and prospects, were materially false and misleading at all relevant times.

After the market closed on March 4, 2019, during Adamas's Q4 2018 conference call with investors, Adamas walked back its previous prescription growth estimates for GOCOVRI, warned of a continued slow-down in GOCOVRI prescriptions, and refused to make further predictions about GOCOVRI's ability to achieve a sizeable market share. On this news, Adamas's stock fell $3.99 per share, or 32.84%, to close at $8.16 per share on March 5, 2019.

On September 30, 2019, Bank of America/Merrill Lynch analyst Tazeen Ahmad lowered its rating for Adamas shares to "Underperform" noting "existing overhangs for ADMS: (1) Gocovri coverage: a number of national formularies exclude Gocovri. We expect reimbursement hurdles in MSWI space especially with generic Ampyra launch." On this news, Adamas shares fell a further 42.83% from $7.05 per share on September 26 to $4.03 by October 3, 2019.

If you purchased Adamas securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/adamaspharmaceuticalsinc-adms-shareholder-class-action-lawsuit-stock-fraud-229/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

If you wish to serve as lead plaintiff, you must move the Court no later than February 10, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

ReleaseID: 570470

BALA CYNWYD, PA / ACCESSWIRE / December 18, 2019 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, or calling toll free 877-534-2590. There is no cost or financial obligation to you.

CONTINENTAL BUILDING PRODUCTS, Inc. (NYSE:CBPX)

Under the terms of the agreement, Continental shareholders will receive only $37.00 for each share of Continental common stock owned. The investigation concerns whether the Continental Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Saint-Gobain SA is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for many Continental shareholders. For example, the stock traded above the deal consideration as recently as September 2018.

Additional information can be found at http://www.brodskysmith.com/cases/continental-building-products-inc-nyse-cbpx/, or call 877-534-2590. No cost or obligation to you.

INSTRUCTURE, INC. (NYSE:INST)

Under the terms of the agreement, Instructure shareholders will receive only $47.60 for each share of Instructure common stock owned. The investigation concerns whether the Instructure Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Thoma Bravo is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for many Instructure shareholders. For example, the stock was trading over $53 a share in November 2019 and at least one analyst following the Company has set a price target of $56.00

Additional information can be found at http://www.brodskysmith.com/cases/instructure-inc-nyseinst/, or call 877-534-2590. No cost or obligation to you.

TD AMERITRADE (Nasdaq:AMTD)

Under the terms of the agreement, TD Ameritrade shareholders will receive only 1.0837 shares of Charles Schwab stock for each share of TD Ameritrade common stock owned. This exchange ratio implied a deal price of $52.23 as of the last day of trading before the announcement. The investigation concerns whether the TD Ameritrade Board breached its fiduciary duties to shareholders by failing to conduct a fair process and whether Charles Schwab is underpaying for the Company. The transaction may undervalue the Company and would result in a substantial loss for many TD Ameritrade shareholders. For example, at least one analyst following the Company has set a price target of $60.00. Additionally, the implied deal price is well-below the 52-week high of $57.88.

Additional information can be found at http://www.brodskysmith.com/cases/td-ameritrade-holding-corporation-nasdaqgs-amtd/, or call 877-534-2590. No cost or obligation to you.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 570417

NEW YORK, NY / ACCESSWIRE / December 18, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

TWTR Shareholders Click Here: https://www.zlk.com/pslra-1/twitter-inc-loss-form?prid=4951&wire=1
CGC Shareholders Click Here: https://www.zlk.com/pslra-1/canopy-growth-corporation-loss-form?prid=4951&wire=1
BZUN Shareholders Click Here: https://www.zlk.com/pslra-1/baozun-inc-loss-form?prid=4951&wire=1

* ADDITIONAL INFORMATION BELOW *

Twitter, Inc. (NYSE:TWTR)

TWTR Lawsuit on behalf of: investors who purchased August 6, 2019 – October 23, 2019
Lead Plaintiff Deadline: December 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/twitter-inc-loss-form?prid=4951&wire=1

The filed complaint alleges that defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated Twitter's common share price and operated as a fraud or deceit on purchasers of Twitter common stock by misrepresenting the Company's operating condition and future business prospects. The scheme was perpetrated by making positive statements about Twitter's business while defendants knew, or disregarded with deliberate recklessness, certain adverse facts. When defendants' prior misrepresentations were disclosed and became apparent to the market, the price of Twitter's common stock fell precipitously.

Canopy Growth Corporation (NYSE:CGC)

CGC Lawsuit on behalf of: investors who purchased June 21, 2019 – November 13, 2019
Lead Plaintiff Deadline: January 20, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/canopy-growth-corporation-loss-form?prid=4951&wire=1

According to the filed complaint, during the class period, Canopy Growth Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Baozun Inc. (NASDAQ:BZUN)

BZUN Lawsuit on behalf of: investors who purchased Baozun American Depository Receipts between March 6, 2019 and November 20, 2019
Lead Plaintiff Deadline: February 10, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/baozun-inc-loss-form?prid=4951&wire=1

According to the filed complaint, (a) Baozun was heavily reliant upon a single brand partner, Huawei, for the exponential service fee growth it had been reporting historically, which was in turn fueling its historical revenue growth; (b) compared to other brands Baozun had as brand partners, the Huawei work had historically included a lot of additional add-on service fees, increasing the revenue reported from Huawei vis-a-via its other brand partners; (c) Huawei, like other large brands, was actively preparing to bring its online merchandising in-house, meaning Baozun knew that it was losing a significant brand partner; and (d) as a result of the foregoing, the Company was not on track to achieve the financial results and performance Defendants claimed the Company was on track to achieve during the class period.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570720

Spokane's DG Contracting wraps up 2019 with a wave of testimonials praising the firm's hardworking, friendly, and respectful team

SPOKANE, WA / ACCESSWIRE / December 18, 2019 /  After a successful year for Spokane County-based DG Contracting, the company has now attracted hundreds of five-star reviews, and has scooped a number of prestigious awards from websites such as HomeAdvisor. Wrapping up 2019 with a wave of glowing all-new testimonials, the firm and its team look forward to 2020 and beyond, and share a closer look at what their delighted clients are saying.

"The work I had done by DG Contracting was top quality, and was completed faster than I anticipated," said client Brad in a review earlier this year. Another review, meanwhile, courtesy of client Mark, went on, "What a great experience working with DG Contracting – these guys are top-notch."

Further reviews go on to praise the company for its hard work, conscientious approach to repairs and reroofing, polite and respectful crew, and immaculate post-job clean-ups.

Also this year, Spokane County-based DG Contracting, which serves clients in Spokane, Post Falls, Cheney, Four Lakes, Rockford, Worley, and surrounding areas, has been top-rated on HomeAdvisor. DG Contracting is currently rated 4.97/5 based on almost 150 verified ratings. Rated by criteria, the firm scores 5/5 for quality, 5/5 for value for money, and 5/5 for customer service. HomeAdvisor, the service says, provides its users with the tools and resources needed to complete their home maintenance, repair, and improvement projects.

"DG Contracting and their crew are the best!" says DG Contracting's latest five-star HomeAdvisor review. "DG Contracting were timely and accomplished everything we requested during a difficult weather period, including snow, rain, and freezing temperatures," suggests another recent review on the platform. "Can't say enough positive things other than the roof looks great!" concludes the same testimonial for DG Contracting.

This year, DG Contracting has also earned a number of HomeAdvisor awards, including HomeAdvisor Top Rated Professional, Best of HomeAdvisor, HomeAdvisor Elite Service Professional, and HomeAdvisor Seal of Approval.

Throughout 2019, the DG Contracting team has spoken at length on topics ranging from the Equipter RB4000's role in protecting owners' properties to the benefits of Timberline roofing shingles.

The contracting firm also touched on its 15-year warranty on workmanship. "At DG Contracting, we believe, first and foremost, that the customer is always right," said a company spokesperson at the time, "and we take great pride in our workmanship, and in improving our clients' treasured properties."

"Let the professionals help," they went on, wrapping up, "and rest assured that, backed by our industry-leading 15-year warranty on workmanship, DG Contracting is the Spokane County roofing company for the job."

CONTACT:
Caroline Hunter
Web Presence, LLC
+1 7862338220

SOURCE: Web Presence

ReleaseID: 570718

LOS ANGELES, CA / ACCESSWIRE / December 18, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AZZ Inc. ("AZZ" or "the Company") (NYSE:AZZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between July 3, 2018 and October 8, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 3, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. AZZ failed to maintain appropriate and effective controls on financial reporting. The Company's improper implementation of ASC 606 resulted in incorrect revenue reconciliations. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about AZZ, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570723

Private Investment Firm Led By Phillip Sarofim Adds Nine Companies To Its Portfolio And Leads New Investment Rounds For Another Three Companies

AUSTIN, TX / BEVERLY HILLS, CA / ACCESSWIRE / December 18, 2019 / Trousdale Ventures, LLC (www.trousdalevc.com), a privately-held investment company with offices in Austin and Los Angeles, wraps up 2019 with the addition of nine growth companies to its portfolio along with the leading of new investment rounds for another three existing companies. "2019 marks a year of substantial portfolio growth for Trousdale Ventures, with investment in companies that range from seed stage to those having achieved impressive brand recognition. Each of our portfolio companies share in common highly motivated and deeply committed management, and unique products and services that will change lives for the better," said Phillip Sarofim, Chief Executive Officer.

Phillip Sarofim, CEO Trousdale Ventures, LLC

New to the Trousdale Ventures investment portfolio are innovative companies at the leading edge of technology, clean energy and consumer products, including:

SkinTè – An innovative beauty and wellness beverage, SkinTè is offered in multiple flavors specially formulated with a combination of collagen, super herbs, and real brewed teas to promote daily well-being.

Glas̄™ – Raising industry standards to new levels, Glas̄™ is an award-winning, internationally recognized retailer of premium e-liquid and devices for legal vaping use with a reputation for maintaining the highest levels of integrity, quality and customer service. Its mission is to enhance peoples' lives, self-esteem and confidence and convert existing smokers to a reduced-risk product that will improve the general health of the smoking population.

KITU Super Coffee – A burgeoning brand that is impacting the retail beverage category, KITU Super Coffee boasts a coffee, creamer and expresso delivering a delicious blend of sugar-free, lactose-free, soy-free and gluten-free real ingredients for all day energy.

KEY Concierge – KEY created the first concierge and hospitality marketplace. To address the current gap in the short-term rental industries, KEY delivers localized, hotel-like services and amenities to travelers along with hospitality and up-leveling services to both property managers and hosts.

Passport Global Foods – A leading national cultural food producer-distributor, Passport Global Foods was originally founded in 1978 and is recognized industry-wide as a premier provider of quality snack and mealtime traditional favorites with a contemporary touch distributed to hundreds of grocery, club and retail accounts throughout the country.

Collective Labs – Introducing a bold, new approach to hair loss, Collective Laboratories combines rare ingredients from nature with advanced science to create a breakthrough formula f

Open Lending – Open Lending provides automated lending services to financial institutions. Its flagship product, the Lenders Protection Program, is a unique auto lending program for direct and indirect loans that provides a powerful and safe way for lenders to increase near and non-prime auto loan volumes and yields without adding risk to their loan portfolio.

ManifestSeven – Formerly known as MJIC, ManifestSeven is the first integrated, omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway. Spanning the state of California, ManifestSeven services the needs of lawful operators across the supply chain and also has its own growing portfolio of owned and operated retail operations.

Selina – A travel, lifestyle and hospitality platform for the digital nomad; Selina has built a global network of destinations that connect locals and travelers with unique, immersive, purpose-filled and unforgettable hospitality experiences, matched with the technological amenities befitting a true digital nomad.

In addition to investment companies added in 2019 to the Trousdale Ventures portfolio, the firm has also led financing rounds for three of its existing portfolio companies, including Hive 9, Yellowbird Sauce, and Good Shepherd Entertainment. Hive9, an Austin-based provider of B2B marketing solutions, is a leader and innovator in Marketing Performance Management, helping enhance the financial operations, strategic alignment and business performance of each client's marketing program. Yellowbird Sauce is a favorite at top retailers and restaurants nationwide celebrated for its superior spicy condiments that are filled with flavor and packed with real farm-fresh fruits and vegetables to offer a deliciously thicker and smoother consistency. Good Shepherd Entertainment is a top-ranked global video game publisher and marketing force behind many of the biggest IP's from the gaming industry's most prolific developers.

In addition, KITU Super Coffee, Trousdale Ventures and global investment firm Skyview Capital, LLC invested in KITU Super Coffee in 2018. The energy-boosting beverage line boasting a coffee, creamer and expresso delivering a delicious blend of sugar-free, lactose-free, soy-free and gluten-free real ingredients for all day energy, continues its impressive growth online as well as with prestigious retailers nationwide.

Founder and CEO Phillip Sarofim established the firm with an extensive background in corporate investment, business development and mergers and acquisitions. He takes an active role in helping grow portfolio companies as a member of the Advisory Board or Board of Directors and serves on the Board of Directors for Yellowbird Foods, Passport Global Foods, Glas̄™ and Good Shepherd Entertainment. Sarofim also serves on the Advisory Boards of Trousdale portfolio companies EQTainment and Ostendo. Sarofim also serves outside of the direct Trousdale Ventures portfolio on the Advisory Boards of Unicorn Ventures and Skyview Capital, LLC. Unicorn Ventures is a venture capital firm focused on providing seed funding to early-to-mid stage companies and Skyview Capital, LLC is a global independent investment firm, which ranks among Trousdale Ventures' key strategic investment partners.

About Trousdale Ventures: Trousdale Ventures, LLC (https://trousdalevc.com/) is a privately held investment firm owned and managed by partners Phillip Sarofim and Brian Grigsby. Its portfolio encompasses a variety of companies involved in technology, food manufacturing, lifestyle, consumer and child development products.

# # #

CONTACT: SSA Public Relations

Steve Syatt
steve@ssapr.com
(818) 222-4000

SOURCE: SSA Public Relations

ReleaseID: 570715

NEW YORK, NY / ACCESSWIRE / December 18, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to make a motion to serve as lead plaintiff in a securities class action on behalf of investors that purchased or acquired the securities of Fiat Chrysler Automobiles N.V., Inc. ("Fiat" or the "Company") (NYSE:FCAU) between February 26, 2016 and November 20, 2019, inclusive (the "Class Period"). The lawsuit filed in the United States District Court for the Eastern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Fiat securities, and/or would like to discuss your legal rights and options please visit Fiat FCAU Shareholder Class Action or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Fiat employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with International Union, United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat official were aware of and authorized the scheme; and (3) due to the foregoing, defendants' statements about Fiat's receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On November 20, 2019, General Motors filed a racketeering lawsuit against Fiat in the Eastern District of Michigan for damages caused by a bribery scheme perpetuated by the UAW and Fiat.

On this news, shares of Fiat fell $0.58 per share or nearly 3.72% to close at $15.00 per share on November 20, 2019.

If you purchased Fiat securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/fiatchryslerautomobilesnv-fcau-shareholder-class-action-lawsuit-stock-fraud-223/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

If you wish to serve as lead plaintiff, you must move the Court no later than January 30, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
http://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

ReleaseID: 570133

Not for distribution to US newswire services or dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / December 18, 2019 / TerraX Minerals Inc. (TSX-V:TXR) (Frankfurt:TX0) (OTC Pink:TRXXF) ("TerraX" or the "Company") is pleased to announce that at the Annual General and Special Meeting of the shareholders held on December 17, 2019 (the "Meeting"), the shareholders elected Gerald Panneton, David Suda, Stuart Rogers, Louis Dionne, Elif Lévesque, Laurie Gaborit and Russell Starr as directors of the Company for the forthcoming year. All motions, including the amendments to the Company's stock option plan and appointment of the Company's auditors, were passed by a majority of the shares represented in person or by proxy, showing strong support from voting shareholders.

David Suda, President and CEO, stated "I would like to thank outgoing directors Joe Campbell, Rene Carrier and Paul Reynolds for their contribution to TerraX. Joe Campbell will continue his involvement with the Company as COO to oversee the upcoming drill program in 2020."

About TerraX

Through a series of acquisitions, TerraX owns a 100% interest in the Yellowknife City Gold ("YCG") Project, encompassing 783 sq km of contiguous land within 12 kilometers of the city of Yellowknife. The Project is located in the prolific Yellowknife greenstone belt, covering 70 kilometers of strike length along the main mineralized break in proximity to the former high-grade Con and Giant gold mines which have produced over 14 million ounces of gold. The YCG Project is close to vital infrastructure, including all-season roads, air transportation, service providers, hydro-electric power and skilled tradespeople.

For more information on the YCG project, please visit our web site at www.terraxminerals.com.

On behalf of the Board of Directors,

"DAVID SUDA"

David Suda
President and CEO

For more information, please contact:

Samuel Vella
Manager of Corporate Communications
Phone: 604-689-1749 / Toll-Free: 1-855-737-2684
svella@terraxminerals.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: TerraX Minerals Inc.

ReleaseID: 570707

NEW YORK, NY / ACCESSWIRE / December 18, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

UP Fintech Holding Limited (NASDAQ:TIGR)
Class Period: all persons and entities that purchased or otherwise acquired: (a) Fintech American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 20, 2019; or (b) Fintech securities between March 20, 2019 and May 16, 2019.
Lead Plaintiff Deadline: January 6, 2020

The TIGR lawsuit alleges that throughout the class period, UP Fintech Holding Limited made materially false and/or misleading statements and/or failed to disclose that: (i) Fintech was experiencing a material decrease in commissions because of a negative trend related to risk-averse investors in the market; (ii) Fintech was unable to absorb costs associated with the rapid growth of its business and its status as a publicly listed company on a U.S. exchange; (iii) Fintech was incurring significant additional expenses related to, inter alia, employee headcount and employee compensation and benefits; (iv) all of the foregoing had led to Fintech significantly increasing operating costs and expenses; and (v) as a result, the documents filed by the Company in connection with the initial public offering were materially false and/or misleading and failed to state information required to be stated therein, and the Company's Class Period statements were likewise materially false and/or misleading.

Learn about your recoverable losses in TIGR: http://www.kleinstocklaw.com/pslra-1/up-fintech-holding-limited-loss-submission-form?id=4950&from=1

Yunji Inc. (NASDAQ:YJ)
Class Period: on behalf of shareholders who purchased or otherwise acquired Yunji American Depositary Shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's May 2019 initial public offering.
Lead Plaintiff Deadline: January 13, 2020

Yunji Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was shifting certain of its sales to its marketplace platform; (2) this supply chain restructuring was likely to disrupt Yunji's relationships with suppliers; (3) this supply chain restructuring was likely to have an adverse impact on the Company's financial results; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in YJ: http://www.kleinstocklaw.com/pslra-1/yunji-inc-loss-submission-form?id=4950&from=1

X Financial (NYSE:XYF)
Class Period: X Financial American Depositary Shares pursuant and/or traceable to the Company's September 19, 2018 initial public offering.
Lead Plaintiff Deadline: February 7, 2020

According to the complaint, X Financial allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's total loan facilitation amount was not growing, but rather was contracting; (ii) the number of investors actively using X Financial's platform was shrinking; (iii) demand from small- and medium-sized enterprises for the Company's preferred loans was plummeting; (iv) the Company's preferred loans had performed so poorly that it had begun drastically scaling back its preferred loans in the first quarter of 2018, several months before the initial public offering ("IPO"), and was in the process of phasing out such loans completely; (v) demand for the Company's card loans was also plummeting; (vi) the revenue and loan facilitation growth provided in the registration statement leading up to the IPO was achieved by relaxed credit and due diligence standards, under which the Company had underwritten tens of millions of dollars' worth of poor quality loans that suffered from a disproportionately high risk of default as compared to the Company's earlier loan vintages; (vii) the Company was suffering from accelerated delinquency rates from poor quality loans that it had underwritten in the first, second, and third quarters of 2018, which had caused the Company's delinquency rate to sharply rise; (viii) the Company's product mix had significantly deteriorated; (ix) the Company's net revenue was on track to decline by 22% during the third quarter of 2018; and (x) as a result, the Registration Statement was materially false and/or misleading and failed to state information required to be stated therein.

Learn about your recoverable losses in XYF: http://www.kleinstocklaw.com/pslra-1/x-financial-loss-submission-form?id=4950&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 570713